跳至主要内容
临床试验/NCT04735744
NCT04735744Unknown不适用

Evaluation of Allied Healthcare in Patients Recovering From COVID-19

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 1,441 人开始时间: 2021年3月29日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,441
试验地点
1
主要终点
Nutritional Status

研究概览

简要总结

SUMMARY Rationale: Allied health professionals (i.e., dietitians, exercise therapists, physical therapists, occupational therapists and speech and language therapists) might play an important role in the recovery of patients with COVID-19 who experience limitations in daily physical functioning and participation. However, the evidence base for allied healthcare in patients with COVID-19 has yet to be established. To facilitate care for people recovering from COVID-19 and to establish this evidence base, the Dutch ministry has created a temporary regulation for primary care allied healthcare specifically for patients with COVID-19.

Objective: This study is setup alongside the temporary regulation and aims to evaluate the longitudinal recovery trajectories and related costs of patients who visited a primary care allied healthcare professional for the management of severe symptoms and activity limitations and/or participation restrictions related to COVID-19.

Study design: Prospective cohort study. Study population: 1,315 adult patients recovering from COVID-19 with severe symptoms and activity limitations and/or participation restrictions, and who are referred to a primary care allied health professional by a general practitioner or medical specialist within four months of the start of the disease will be eligible for this study.

Intervention (if applicable): Although the nature of this study is non-experimental, the allied healthcare intervention can be considered experimental due to the novelty of the disease.

Main study parameters/endpoints: The primary outcome domain of this study is participation measured with the Utrechtse Schaal voor Revalidatie - Participatie (USER-P). The primary endpoint is set at 6 months. A 5 point difference will be considered clinically relevant for patients with COVID-19.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There are no specific risks involved with participation in this study, as it entails the completion of questionnaires over the timeframe of one year (at the start of the treatment, the end of the treatment, 3 months, 6 months, 9 months and 12 months). The load of the survey will be highest at months 3, 6 and 12 with a total of 74 survey items. Input from patient representatives suggested that this number of items was feasible, especially because participants are allowed to complete the survey over a number of days. Finally, none of the items in the survey are considered emotionally distressing. The prescribed interventions are conform the recommendations of the best available evidence and are in line with usual allied healthcare interventions. Therefore, risks are likely to be negligible conform usual allied healthcare.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients
  • recovering from COVID-19 with severe symptoms and activity limitations and/or participation restrictions, and;
  • who are referred to a primary care allied health professional by a general practitioner or medical specialist within four months of the start of the disease; will be eligible for this study. The need for referring the patient to an allied health professional will be judged by the primary care physician or medical specialist. Criteria for referral are described in guidance published by the Long Alliantie Nederland (LAN) with recommendations for treatment of post-COVID-19-patients: the COVID-19 Associated Syndrome (CAS) (Chapters 3.3 and 4).
  • http://www.longalliantie.nl/files/2515/9359/4621/Handreiking_voor_de_zorg.pdf

排除标准

  • Adult patients:
  • receiving palliative care; are excluded from this study.

结局指标

主要结局

Nutritional Status

时间窗: end of the treatment as part of usual care (average of 6 months)

measured with the BMI (weight and height)

Global Assessment

时间窗: end of the treatment as part of usual care (average of 6 months)

measured with the PG-SGA short form weight history, food intake, symptoms, activities and function).

Participation

时间窗: 12 months (T3)

Measured with the Utrecht Scale for Evaluation of Rehabilitation Participation (USER-P) (32 items)

Fatigue

时间窗: 12 months (T3)

Measured with the Fatigue Severity Scale (FSS)

Costs

时间窗: 12 months (T4)

will be measured using a cost questionnaire (18 items)

Patient Specific Activities

时间窗: end of the treatment as part of usual care (average of 6 months)

measured with the Canadian Occupational Performance Measure (COPM)

Quality of life measured with EQ-5D-5L

时间窗: 12 months (T3)

Measured with the EuroQol five-dimensional questionnaire (EQ-5D-5L) (5 items)

Physical functioning

时间窗: 12 months (T3)

PROMIS Physical Functioning Short Form 10b (10 items).

Voice Problems

时间窗: end of the treatment as part of usual care (average of 6 months)

measured with Voice Handicap Index (VHI)

Swallowing Problems

时间窗: end of the treatment as part of usual care (average of 6 months)

Dysphagia Handicap Index (DHI).

Activities

时间窗: end of the treatment as part of usual care (average of 6 months)

measured with the PRO-ergo

次要结局

  • Bioimpedance (BIA(end of the treatment as part of usual care (average of 6 months))
  • Voice Problems(end of the treatment as part of usual care (average of 6 months))
  • VAS-appetite, taste and smell(end of the treatment as part of usual care (average of 6 months))
  • Liquid medical nutrition(end of the treatment as part of usual care (average of 6 months))
  • Sarcopenia(end of the treatment as part of usual care (average of 6 months))
  • Exercise capacity(end of the treatment as part of usual care (average of 6 months))
  • Quadriceps strength(end of the treatment as part of usual care (average of 6 months))
  • Hand grip strength(end of the treatment as part of usual care (average of 6 months))
  • Dietary goal attainment(end of the treatment as part of usual care (average of 6 months))
  • Types of Stool(end of the treatment as part of usual care (average of 6 months))
  • Swallowing Problems(end of the treatment as part of usual care (average of 6 months))
  • Physical Functioning(end of the treatment as part of usual care (average of 6 months))
  • Cognitive Functioning(end of the treatment as part of usual care (average of 6 months))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验